Management team

Martin_Amark_DSC_5294_384x384px

MARTIN ÅMARK
CEO

Martin Åmark holds a M Sc. in industrial engineering and management from Linköping Institute of Technology and a MBA from INSEAD. He has 8 years of experience from Bain & Co as a management consultant. At Bain Martin worked mainly with M&A, strategy and organisation with Nordic clients across multiple industries, including life science and pharmaceuticals.

DSC_2987_bw_368px

SIAVASH BASHIRI
COO & HEAD OF BIOSIMILARS

Siavash Bashiri holds a M Sc. in Molecular Biotechnology from Uppsala University. His latest position was with Agilent Technologies where he was the head of sales in EMEA for one of Agilent Technologies’ products within the Genomics department. He also has great knowledge of the commercialization of biotech start-ups from previous experiences.

DSC_3175_bw_whiteback_368px

DR. DAVID VIKSTRÖM
CTO

David Vikström is the CTO of Xbrane Bioscience. He has a Ph.D. in expression and targeting of proteins in E. coli. He joined Xbrane in 2010 and successfully developed new technologies and strains for vaccine candidates. He is currently heading the development of Xbrane’s new expression systems to be able to take the expression in E. coli to new levels.

DSC_9519-2

DR. PAOLO SARMIENTOS
HEAD OF CONTROLLED RELEASE GENERICS

Paolo Sarmientos has a Ph.D in bio-organic chemistry from the University of Naples. He has more than 25 years of experience from leading positions in biopharmaceuticals for Pfizer, Genetica and Menarini. Last 15 years Paolo has served as CEO of Primm and successfully built up a service business focused on pharmaceutical industries as well as pioneering technology for production of biopharmaceuticals with slow release formulation based on microspheres.

DSC_9505-2

DR. CARLO COLOMBO
HEAD OF PRODUCTION CONTROLLED RELEASE GENERICS

Carlo holds a M Sc. in Industrial Chemistry from the University of Milano. He has more than 15 years of experience from pharmaceutical manufacturing from API manufacturers ICI and Euticals. He has held positions as site director for 5 different API production plants across Euticals and ICI, latest as site director for ICI Cellole plant. He has ample experience from all aspects of pharmaceutical manufacturing including regulatory requirements (GMP), process and supply chain optimization and quality control.